Functional brain network mechanism of executive control dysfunction in temporal lobe epilepsy

BMC Neurology

Table 1 Group demographics of the TLE patients and the HCs

	TLE (n = 20)	HCs (n = 20)	Test value	P-value
Age (Mean ± SD)	29.30 ± 10.32	27.55 ± 7.05	^a-1.75	0.54
Gender (Male/Female)	10/10	11/9	^b0.1	0.75
MoCA (Mean ± SD)	28.05 ± 1.39	28.15 ± 1.63	^a0.21	0.84
Age of epilepsy onset	19.50 ± 9.36 (2–50)
Duration (years)	10.10 ± 10.84 (1–42)
Type of seizures^*	20
Focal automatisms seizure	6
Focal atonic seizure	3
Focal clonic seizure	1
Focal tonic seizure	3
Focal autonomic seizure	2
Focal emotional seizure	2
Focal sensory seizure	3
Seizure Frequency (times/month)	0.70 ± 0.96 (0–4)
AED Therapy (n, %):
Monotherapy	9 (45%)
Polytherapy	11 (55%)

MoCA Montreal Cognitive Assessment, AEDs Antiepileptic Drugs, TLE temporal lobe epilepsy, HCs healthy controls, SD standard deviation. ^a t value; ^bχ2 valuel; ^*According to ILAE 2017 seizure classification [31]

ISSN: 1471-2377